MedTrace Logo

Ritodrine in Oral Maintenance of Tocolysis After Active Preterm Labor

NCT00290173 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL

Last updated 2006-05-04

No results posted yet for this study

Summary

This is a trial comparing the efficacy of oral ritodrine in the form of sustained release capsules for the maintenance of uterine quiescence after successfully treated episode of threatened preterm labor.

Conditions

  • Pregnancy

Interventions

DRUG

efficacy of oral ritodrine in maintaining uterine quiescence

Sponsors & Collaborators

  • Ministry of Science, Education and Sport, Republic of Croatia

    collaborator OTHER_GOV

  • University of Zagreb

    lead OTHER

Principal Investigators

  • Ozren Grgic, MD · Sveti Duh Hospital

  • Ratko Matijevic, MD,PhD · Sveti Duh Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Completion
2005-08-31

Countries

  • Croatia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00290173 on ClinicalTrials.gov